2026 NPPES data Dermatopathology (Pathology) Physician NPI 1245220698 M.D.
Verify on CMS →

Laertes Manuelidis, M.D.

Dermatopathology (Pathology) Physician in Fort Myers, Florida.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 569 in Dermatopathology (Pathology) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 657 beneficiaries · Dermatopathology (Pathology) Physician avg: 434
Generic prescribing
96%
generic claims · 4% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
CMS neutral threshold · no category scores published
Industry payments
$29.2K
49 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

Laertes Manuelidis, M.D. carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 1,696 Medicare Part D claims in 2024.

75/100
CMS neutral score · not measured
2K
Part D claims, 2024
96%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Laertes Manuelidis, M.D.

Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1245220698), first enumerated 10/26/2005.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 1,696 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    CMS quality reporting (MIPS)

    CMS assigned a neutral MIPS final score of 75/100 where no performance category was scored — not a measured quality rank.

    Source: CMS Quality Payment Program

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Hospital affiliations

    1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.

    Source: CMS Care Compare

  • Reported

    Industry payment transparency

    $29.2K in reported industry payments (49 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.

    Source: CMS Open Payments

  • State context

    State board disciplinary context

    Florida statewide board action statistics are published annually — these figures describe aggregate state activity, not Laertes Manuelidis, M.D.'s individual license status. Verify directly with the state medical board.

    Source: FLDOH annual report 2023

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

Compare Manuelidis with other Dermatopathology (Pathology) Physician providers

Same primary specialty, same federal CMS NPPES roster.

Also enrolled in Florida

Other specialties in Fort Myers: Behavior Technician (831) · Physician Assistant (357) · Mental Health Counselor (353) · Family Nurse Practitioner (351)

CMS NPPES provider registry desk

NPI 1245220698 · Dermatopathology (Pathology) Physician

NPI-10 · ENUM-LEGACY · TAX-NARROW · MIPS-NEUTRAL · RX-MID · BOOK-THIN · PHOTO-ENUM

  • NPI-10 1245220698
  • ENUM-LEGACY 2005
  • TAX-NARROW 569
  • MIPS-NEUTRAL 75/100
  • RX-MID 1,696
  • BOOK-THIN 49 in Florida
  • PHOTO-ENUM Hassan Shamma, MD · 2005

Laertes Manuelidis, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2024, across all CMS prescribers nationally

1,696 ≥ 81st percentile 81% of 1,416,883 prescribers are in lower value bands

0–200: 679,947 prescribers (48%). Below this entry. 200–400: 188,835 prescribers (13%). Below this entry. 400–600: 95,866 prescribers (7%). Below this entry. 600–800: 60,107 prescribers (4%). Below this entry. 800–1,000: 43,043 prescribers (3%). Below this entry. 1,000–1,200: 33,612 prescribers (2%). Below this entry. 1,200–1,400: 27,889 prescribers (2%). Below this entry. 1,400–1,600: 23,183 prescribers (2%). Below this entry. 1,600–1,800: 19,917 prescribers (1%). This entry sits in this band. 1,800–2,000: 17,585 prescribers (1%). Above this entry. 2K+: 226,899 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2024

Board certification likely (heuristic, not verified)

Laertes Manuelidis, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Laertes Manuelidis, M.D.?

CMS neutral score, not measured

NPI registry status

Active

Issued 10/26/2005

NPI 1245220698

Primary specialty

Dermatopathology (Pathology) Physician

Niche

569 US NPIs in this specialty

Medicare Part D claims

1,696 291% vs specialty avg

2024 prescription claims

Specialty avg: 434

MIPS final score

75/100

CMS neutral score, not measured

No category scores published; CMS assigned the performance threshold

Specialty distribution in Florida

How Dermatopathology (Pathology) Physician compares to other specialties among Florida providers

Florida providers
Behavior Technician16.3%Mental Health Counselor4.8%Family Nurse Practitioner4.5%Pharmacist4.1%Student in an Organized Heal…4.1%Physical Therapist3%Dermatopathology (Pathology)…0%
Largest specialties in Florida (% of in-state providers)

MIPS score not measured

CMS assigned a neutral 75/100 threshold

CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

8381 RIVERWALK PARK BLVD
Fort Myers, FL 33919

Provider Details

NPI 1245220698
Specialty Dermatopathology (Pathology) Physician
Credentials M.D.
Gender Male
NPI Issued 10/26/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75
Final Score
CMS neutral threshold · not measured

Reporting: Group practice

Hospital and facility affiliations

Facilities where Laertes Manuelidis, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Associates IN Dermatology M D P L
Fort Myers, FL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Laertes Manuelidis, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$29.2K

Largest payer

SUN PHARMACEUTICAL INDUSTRIES INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - Florida FLDOH 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Laertes Manuelidis, M.D.. To verify Laertes Manuelidis, M.D.'s current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

Laertes Manuelidis, M.D. - brand share 4.0%
Dermatopathology (Pathology) Physician average

4% brand-name claims vs 96% generic, on 1,696 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

1,696
Total Claims
$429K
Total Drug Cost
657
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,941.367
Total Day Supply
48,554
Brand vs Generic
4% brand / 96% generic
Brand Drug Cost
$390K
Generic Drug Cost
$39K
Antibiotic Claims
164

Patient Demographics

Average Patient Age
77.7 years
Avg HCC Risk Score
1.48
Gender Split
47% female / 53% male
Age Distribution
<65: 11, 65-74: 207, 75-84: 329, 85+: 110

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Laertes Manuelidis, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Triamcinolone Acetonide
180
Mupirocin
165
Hydrocortisone
158
Clobetasol Propionate
142
Ketoconazole
141
Mometasone Furoate
89
Clindamycin Phosphate
79
Doxycycline Hyclate
75
Fluconazole
57
Valacyclovir
Valacyclovir Hcl
47

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatopathology (Pathology) Physician Overview

How Laertes Manuelidis, M.D. fits within the Dermatopathology (Pathology) Physician landscape nationally.

569
Dermatopathology (Pathology) Physician Providers in US
49
States with Dermatopathology (Pathology) Physician
434
Avg Claims per Provider

Laertes Manuelidis, M.D.'s 1,696 claims are above the specialty average of 434.

Nationwide Dermatopathology (Pathology) Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Manuelidis, both outside Florida so the neighborhoods are not geographic containment.

Similar MIPS final score

Nearest same-specialty clinicians by CMS MIPS final score (75 here).

Same NPPES enumeration year (2005)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Dermatopathology (Pathology) Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Manuelidis.

One of 49 Dermatopathology (Pathology) Physician providers enrolled in Florida, 11 are shown on this page.

Compare Dermatopathology (Pathology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Laertes Manuelidis, M.D.'s specialty?
Laertes Manuelidis, M.D. specializes in Dermatopathology (Pathology) Physician and practices in Fort Myers, Florida. Credentials: M.D..
How much does Laertes Manuelidis, M.D. prescribe under Medicare Part D?
In 2024, Laertes Manuelidis, M.D. wrote 1,696 Medicare Part D claims totaling $429K in drug costs for 657 beneficiaries.
What is Laertes Manuelidis, M.D.'s Medicare quality score?
Laertes Manuelidis, M.D. has a CMS MIPS Final Score of 75/100. CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score for this clinician, so the final score is the neutral performance threshold CMS assigns rather than a measured result. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Laertes Manuelidis, M.D. located?
Laertes Manuelidis, M.D. is located at 8381 RIVERWALK PARK BLVD, Fort Myers, FL, 33919. Phone: (239) 936-5425.
What is Laertes Manuelidis, M.D.'s NPI number?
Laertes Manuelidis, M.D.'s National Provider Identifier (NPI) is 1245220698, issued on 10/26/2005.
Does Laertes Manuelidis, M.D. prescribe more brand-name or generic drugs?
Laertes Manuelidis, M.D.'s prescribing is 4% brand-name and 96% generic drugs by claim count, with $390K in brand drug costs.
How many Dermatopathology (Pathology) Physician providers are there in the US?
There are 569 Dermatopathology (Pathology) Physician providers across 49 states in the US. The average Dermatopathology (Pathology) Physician provider writes 434 Medicare Part D claims per year.
What drugs does Laertes Manuelidis, M.D. prescribe most often?
Based on 2024 Medicare Part D data, Laertes Manuelidis, M.D.'s most frequently prescribed drugs include Triamcinolone Acetonide, Mupirocin, Hydrocortisone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Laertes Manuelidis, M.D. accept Medicare?
Laertes Manuelidis, M.D. appears in CMS Medicare data with 1,696 Part D claims and 657 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Laertes Manuelidis, M.D.'s credentials?
Laertes Manuelidis, M.D.'s NPI is 1245220698 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.